Drug
Cinacalcet clinical trials
Also written Sensipar and AMG 073.
- studies test it
- 58
- open now
- 0
- in phase 3
- 14
- first study started
- 1998
How studies write it
Studies that test it under each name
Brand
- Sensipar
- 17
Studies by the year they started
57 studies that test it; most in 2010 (8)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 1999 | 1 |
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 8 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 15
- Phase 3
- 14
- Phase 4
- 20
- No phase
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 33 · Other 25
Amgen (30) · Children's Mercy Hospital Kansas City (2) · Seoul National University Hospital (2) · Montefiore Medical Center (2) · VA Office of Research and Development (1) · University Hospital, Rouen (1) · Karolinska University Hospital (1) · Kyowa Kirin China Pharmaceutical Co., Ltd. (1)
Often tested with
Tested in the same studies.
Alendronate (1) · Teriparatide (1) · Denosumab (1) · Paricalcitol (1)
Studies
Open first, then newest update. How each study uses Cinacalcet is read from its arms, and is right about nine times in ten.
Testing it · 58
- Novel Combination Therapy for Osteoporosis in MenCompletedPhase 4VA Office of Research and DevelopmentNCT03994172Written as Cinacalcet
- Evaluation of a Cincalcet Suppression TestCompletedPhase 4University Hospital, RouenNCT01103206Written as cinacalcet
- Cinacalcet to Treat Hypercalcemia in Renal Transplant RecipientsTerminatedPhase 1/2Montefiore Medical CenterNCT00415584Written as Cinacalcet HCl
- Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?CompletedNot applicableKarolinska University HospitalNCT02227264Written as Cinacalcet
- Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPTCompletedPhase 4Kyowa Kirin China Pharmaceutical Co., Ltd.NCT03123406Written as Cinacalcet HCl
- Parathyroid Hormone Level and Growth in Pediatric Patients With ESRD on Regular HemodialysisCompletedPhase 4Tanta UniversityNCT05926570Written as Cinacalcet
- Renal Osteodystrophy: An Individual Management ApproachCompletedNot applicableHartmut Malluche, MDNCT02440581Written as Cinacalcet
- E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular EventsCompletedPhase 3AmgenNCT00345839Written as Cinacalcet
- Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis PatientsCompletedPhase 4The University of Hong KongNCT01447368Written as Cinacalcet
- Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.CompletedPhase 3Peter VestergaardNCT03027557Written as Cinacalcet 30 mg Tablet
- Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney TransplantTerminatedNot applicableMontefiore Medical CenterNCT01011114Written as Cinacalcet
- Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic RicketsCompletedPhase 1Children's Mercy Hospital Kansas CityNCT00195936Written as Cinacalcet
- Calcimimetics in Hypophosphatemic RicketsWithdrawnNot applicableChildren's Mercy Hospital Kansas CityNCT00844740Written as Cinacalcet
- Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet TreatmentCompletedNot applicableMin-Sheng General HospitalNCT04637360Written as Cinacalcet Tablets
- Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on DialysisCompletedPhase 3AmgenNCT02341417Written as Cinacalcet
- Pediatric Chronic Kidney Disease Safety and EfficacyTerminatedPhase 3AmgenNCT01277510Written as cinacalcet capsule
- Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on DialysisTerminatedPhase 3AmgenNCT02138838Written as Cinacalcet HCl
- Study to Evaluate Cinacalcet in Children With Chronic Kidney DiseaseCompletedPhase 1AmgenNCT01290029Written as Cinacalcet
- Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary HyperparathyroidismTerminatedPhase 2AmgenNCT01439867Written as Cinacalcet hydrochloride
- Interaction Between a Calcimimetic Agent and the Renin Angiotensine Aldosterone SystemCompletedNot applicableCentre Hospitalier Universitaire VaudoisNCT01519037Written as Cinacalcet 60 MG
See all 58 studies that test Cinacalcet →
Given in every arm · 2 — Cinacalcet is usual care beside what is tested
- Evaluating Alternative Medical Therapies in Primary HyperparathyroidismCompletedPhase 2/3Brigham and Women's HospitalNCT02525796Written as Cinacalcet
- Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed PatientsTerminatedPhase 3Centre Hospitalier Universitaire, AmiensNCT01011699Written as cinacalcet
As the comparator · 9 — what is tested is compared with Cinacalcet
- Study of MT1013 for the Treatment of Patients With Secondary HyperparathyroidismRecruitingPhase 3Shaanxi Micot Pharmaceutical Technology Co., Ltd.NCT07122401Written as Cinacalcet
- A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing HemodialysisCompletedPhase 2Astellas Pharma IncNCT02133404Written as Cinacalcet
- A Study of SHR6508 in Secondary HyperparathyroidismStatus unknownPhase 2Shanghai Hengrui Pharmaceutical Co., Ltd.NCT05663411Written as Cinacalcet
- Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in AsiaCompletedPhase 3Kyowa Kirin Co., Ltd.NCT03822507Written as Cinacalcet Hydrochloride
- Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)CompletedPhase 3AmgenNCT03299244Written as Cinacalcet
- Head-to-Head Study of Etelcalcetide (AMG 416) and CinacalcetCompletedPhase 3AmgenNCT01896232Written as Cinacalcet
- Phase 2 Study of KHK7580CompletedPhase 2Kyowa Kirin Co., Ltd.NCT02216656Written as KRN1493
- Phase 3 Study of KHK7580CompletedPhase 2/3Kyowa Kirin Co., Ltd.NCT02549391Written as KRN1493
- ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving HemodialysisCompletedPhase 4AmgenNCT00379899Written as cinacalcet
Codes
What other systems call Cinacalcet · ClinicalTrials.gg INT006583
- MeSH (NLM) D000069449CinacalcetConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) UAZ6V7728SCINACALCETConfirmed FDA, NLM, Wikidata
- RxNorm 407990Confirmed FDA, Wikidata
- Wikidata Q193978cinacalcetConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C74100CinacalcetOne source FDA
- DrugBank DB01012One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069449 | Cinacalcet | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | UAZ6V7728S | CINACALCET | Confirmed FDA, NLM, Wikidata |
| RxNorm | 407990 | — | Confirmed FDA, Wikidata |
| Wikidata | Q193978 | cinacalcet | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C74100 | Cinacalcet | One source FDA |
| DrugBank | DB01012 | — | One source Wikidata |
Also registered as cinacalcet hydrochloride (UNII 1K860WSG25 · RxNorm 384379).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.